Status:
COMPLETED
A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis
Lead Sponsor:
Allergan
Conditions:
Hyperhidrosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a three year open-label study in subjects with axillary hyperhidrosis.
Eligibility Criteria
Inclusion
- Marked axillary hyperhidrosis
Exclusion
- Previous use of botulinum toxin for hyperhidrosis
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
424 Patients enrolled
Trial Details
Trial ID
NCT00168480
Start Date
November 1 2003
End Date
April 1 2007
Last Update
September 29 2008
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Portland, Oregon, United States
2
Pinneberg, Germany
3
Gothenburg, Sweden
4
Nottingham, United Kingdom